Meyahealth
HomeGeneticsConditionMicrocephaly, seizures, and developmental delay
Back to Condition
Microcephaly, seizures, and developmental delay
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Microcephaly, seizures, and developmental delay

Microcephaly, seizures, and developmental delay (MCSZ) is a rare genetic disorder characterized by an abnormally small head size and severe neurological issues. It is caused by mutations that prevent the proper repair of damaged DNA in nerve cells.

Description

Microcephaly, seizures, and developmental delay (MCSZ) is a condition characterized by an abnormally small head size (microcephaly) and neurological problems related to impaired brain development before birth. Affected individuals typically have recurrent seizures (epilepsy) beginning in infancy and delayed development of motor skills, such as sitting and walking. Speech is also delayed, and some affected individuals are never able to speak. Intellectual disability and behavior problems, primarily hyperactivity, are also common features of MCSZ. Rarely, individuals with MCSZ also have poor balance and coordination (ataxia).

Frequency

MCSZ is a rare disorder. Its prevalence is unknown.

Causes

MCSZ is caused by mutations in the PNKP gene. This gene provides instructions for making an enzyme that is critical for repairing broken DNA strands. DNA breaks may be caused by potentially harmful molecules (such as reactive oxygen species) produced during normal cellular functions, natural and medical radiation, or other environmental exposures. They may also occur when chromosomes exchange genetic material in preparation for cell division. At the site of damage, the PNKP enzyme modifies the broken ends of the DNA strands so that they can be joined back together.

PNKP gene mutations lead to production of an unstable enzyme that is quickly broken down in the cell. Shortage of the PNKP enzyme prevents efficient repair of damaged DNA. Nerve cells seem especially susceptible to such damage. It is thought that DNA damage that accumulates during development before birth leads to the death of nerve cell precursors, impairing normal brain growth and causing microcephaly and the other neurological features of MCSZ.

Accumulated DNA damage in nerve cells in the brain after birth, particularly the part that coordinates movement (the cerebellum), likely underlies ataxia. It is unclear why some people have cerebellar nerve degeneration after birth in addition to impaired brain development before birth and others do not. Researchers suspect that additional genetic factors play a role.

Associated Gene

  • PNKP

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

  • EIEE10
  • Epileptic encephalopathy, early infantile, 10
  • MCSZ

Frequently Asked Questions

Broad‑spectrum agents such as levetiracetam, topiramate, or valproic acid are commonly used because they address both focal and generalized seizure types. Some patients respond poorly to carbamazepine or phenytoin, which can exacerbate myoclonic components. Because DNA repair deficits may increase sensitivity to drug toxicity, start at low doses and titrate slowly while monitoring liver function and neuro‑cognitive status.
Life expectancy is not precisely defined but many individuals survive into adulthood with appropriate seizure control and supportive care. Intellectual disability is usually moderate to severe, and most adults require assistance with daily living. However, with consistent therapy, some achieve partial independence in mobility and communication, and quality of life can be enhanced by a stable home environment and community support services.
The combination of a head circumference more than 2‑3 standard deviations below the mean at birth or within the first months, onset of focal or generalized seizures before 12 months of age, and delayed motor milestones (e.g., inability to sit unsupported by 9 months) is highly suggestive. When these signs appear together, especially with hyperactivity or ataxia, clinicians should order a chromosomal microarray or targeted sequencing of the PNKP gene to confirm MCSZ.
Early intervention is critical. Physical therapy focusing on trunk control and gait training, combined with occupational therapy for fine‑motor skills, can maximize functional independence. Speech‑language therapy that uses augmentative and alternative communication (AAC) devices helps children who have limited verbal output. Regular neuropsychological assessments guide individualized educational plans and behavioral strategies for hyperactivity.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ